AR016869A1 - Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspensionfarmaceutica - Google Patents
Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspensionfarmaceuticaInfo
- Publication number
- AR016869A1 AR016869A1 ARP980104200A ARP980104200A AR016869A1 AR 016869 A1 AR016869 A1 AR 016869A1 AR P980104200 A ARP980104200 A AR P980104200A AR P980104200 A ARP980104200 A AR P980104200A AR 016869 A1 AR016869 A1 AR 016869A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical
- nevirapine
- suspension
- prepare
- waterproof
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased/Invalidation/Refusal/Rejection/Nullification
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Método para preparar una suspension farmacéutica acuosa de nevirapina que comprende mezclar hemihidrato de nevirapina que tiene un tamano de partículasentre aproximadamente 1 y 150 micrometros, con agua y, discrecionalmente, aditivos farmacéuticosco nvencionales. Suspension farmacéutica que constaesencialmente de hemihidrato de nevirapina que tiene un tamano de partículas entre aproximadamente 1 y 150 micrometros, agua y, discrecionalmente, aditivosfarmacéuticos convencionales. Uso denevirapina para preparar una suspension farmacéutica, la cual contiene hemihidrato de nevirapina y está destinada altratamiento de la infeccion VIH-1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5680397P | 1997-08-25 | 1997-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016869A1 true AR016869A1 (es) | 2001-08-01 |
Family
ID=22006658
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980104200A Ceased/Invalidation/Refusal/Rejection/Nullification AR016869A1 (es) | 1997-08-25 | 1998-08-25 | Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspensionfarmaceutica |
ARP110103815A Pending AR083451A2 (es) | 1997-08-25 | 2011-10-14 | Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspension farmaceutica |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110103815A Pending AR083451A2 (es) | 1997-08-25 | 2011-10-14 | Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspension farmaceutica |
Country Status (38)
Country | Link |
---|---|
US (2) | US6172059B1 (es) |
EP (1) | EP1019058B1 (es) |
JP (1) | JP3472261B2 (es) |
KR (1) | KR100426516B1 (es) |
CN (1) | CN1197578C (es) |
AR (2) | AR016869A1 (es) |
AT (1) | ATE326971T1 (es) |
AU (1) | AU742761B2 (es) |
BG (1) | BG64337B1 (es) |
BR (1) | BR9811994B1 (es) |
CA (1) | CA2301646C (es) |
CL (1) | CL2008003111A1 (es) |
CO (1) | CO4970742A1 (es) |
CY (1) | CY1105228T1 (es) |
CZ (1) | CZ290667B6 (es) |
DE (1) | DE69834655T2 (es) |
DK (1) | DK1019058T3 (es) |
EG (1) | EG24075A (es) |
ES (1) | ES2265666T3 (es) |
HK (1) | HK1027975A1 (es) |
HR (1) | HRP980461B1 (es) |
HU (1) | HU226063B1 (es) |
ID (1) | ID21650A (es) |
IL (1) | IL134185A (es) |
MY (1) | MY122272A (es) |
NO (1) | NO326226B1 (es) |
NZ (1) | NZ503414A (es) |
PE (1) | PE105799A1 (es) |
PL (1) | PL192361B1 (es) |
PT (1) | PT1019058E (es) |
RS (1) | RS49808B (es) |
RU (1) | RU2196584C2 (es) |
SA (1) | SA98190680B1 (es) |
TR (1) | TR200000490T2 (es) |
TW (1) | TW450812B (es) |
UA (1) | UA44370C2 (es) |
WO (1) | WO1999009990A1 (es) |
ZA (1) | ZA987623B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002092095A1 (en) * | 2001-05-11 | 2002-11-21 | Boehringer Ingelheim International Gmbh | Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine |
EP1504040A1 (en) * | 2002-04-23 | 2005-02-09 | Boehringer Ingelheim Pharmaceuticals Inc. | Method for reduction of residual organic solvent in carbomer |
KR20080053317A (ko) * | 2005-08-31 | 2008-06-12 | 씨아이피엘에이 엘티디. | 라미부딘, 스타부딘 및 네비라핀을 포함하는 약학적 조합물 |
US20110082161A1 (en) * | 2008-06-30 | 2011-04-07 | Lieven Elvire Colette Baert | Powders for reconstitution |
BR112012011095A2 (pt) * | 2009-11-10 | 2015-10-06 | Univ Northwest | método para aumentar a solubilidade de uma composição inibidora de transcriptase |
DE112010004862T5 (de) * | 2009-12-17 | 2012-12-06 | North West University | Polymorphe Form von Nevirapin und deren Herstellung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366972A (en) | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
CA2030056C (en) * | 1989-11-17 | 1995-10-17 | Karl D. Hargrave | 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection |
US5571912A (en) * | 1990-10-19 | 1996-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines |
DE4403311C1 (de) * | 1994-02-03 | 1995-04-20 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on) |
-
1998
- 1998-08-11 UA UA2000031668A patent/UA44370C2/uk unknown
- 1998-08-11 AT AT98939312T patent/ATE326971T1/de active
- 1998-08-11 AU AU87771/98A patent/AU742761B2/en not_active Ceased
- 1998-08-11 WO PCT/US1998/016581 patent/WO1999009990A1/en active IP Right Grant
- 1998-08-11 US US09/131,829 patent/US6172059B1/en not_active Expired - Lifetime
- 1998-08-11 BR BRPI9811994-0B1A patent/BR9811994B1/pt not_active IP Right Cessation
- 1998-08-11 KR KR10-2000-7001889A patent/KR100426516B1/ko not_active IP Right Cessation
- 1998-08-11 CA CA002301646A patent/CA2301646C/en not_active Expired - Fee Related
- 1998-08-11 TR TR2000/00490T patent/TR200000490T2/xx unknown
- 1998-08-11 RU RU2000107825/14A patent/RU2196584C2/ru not_active IP Right Cessation
- 1998-08-11 DK DK98939312T patent/DK1019058T3/da active
- 1998-08-11 NZ NZ503414A patent/NZ503414A/xx not_active IP Right Cessation
- 1998-08-11 HU HU0003093A patent/HU226063B1/hu not_active IP Right Cessation
- 1998-08-11 PL PL338828A patent/PL192361B1/pl unknown
- 1998-08-11 EP EP98939312A patent/EP1019058B1/en not_active Expired - Lifetime
- 1998-08-11 JP JP2000507380A patent/JP3472261B2/ja not_active Expired - Fee Related
- 1998-08-11 CN CNB988084899A patent/CN1197578C/zh not_active Expired - Fee Related
- 1998-08-11 ES ES98939312T patent/ES2265666T3/es not_active Expired - Lifetime
- 1998-08-11 DE DE69834655T patent/DE69834655T2/de not_active Expired - Lifetime
- 1998-08-11 PT PT98939312T patent/PT1019058E/pt unknown
- 1998-08-11 CZ CZ2000694A patent/CZ290667B6/cs not_active IP Right Cessation
- 1998-08-11 IL IL13418598A patent/IL134185A/xx not_active IP Right Cessation
- 1998-08-11 RS YUP-98/00A patent/RS49808B/sr unknown
- 1998-08-11 PE PE1998000718A patent/PE105799A1/es not_active Application Discontinuation
- 1998-08-21 MY MYPI98003819A patent/MY122272A/en unknown
- 1998-08-23 EG EG98398A patent/EG24075A/xx active
- 1998-08-24 HR HR980461A patent/HRP980461B1/xx not_active IP Right Cessation
- 1998-08-24 ID IDP981156A patent/ID21650A/id unknown
- 1998-08-24 TW TW087113878A patent/TW450812B/zh not_active IP Right Cessation
- 1998-08-24 CO CO98048247A patent/CO4970742A1/es unknown
- 1998-08-24 ZA ZA9807623A patent/ZA987623B/xx unknown
- 1998-08-25 AR ARP980104200A patent/AR016869A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 1998-11-01 SA SA98190680A patent/SA98190680B1/ar unknown
-
2000
- 2000-02-07 BG BG104133A patent/BG64337B1/bg active Active
- 2000-02-24 NO NO20000906A patent/NO326226B1/no not_active IP Right Cessation
- 2000-03-02 US US09/517,564 patent/US6255481B1/en not_active Expired - Lifetime
- 2000-11-20 HK HK00107393A patent/HK1027975A1/xx not_active IP Right Cessation
-
2006
- 2006-08-11 CY CY20061101147T patent/CY1105228T1/el unknown
-
2008
- 2008-10-21 CL CL2008003111A patent/CL2008003111A1/es unknown
-
2011
- 2011-10-14 AR ARP110103815A patent/AR083451A2/es active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX20055A (es) | Procedimiento para la preparacion de una composicion acuosa de ibuprofen y procedimiento para su preparacion. | |
BR9101466A (pt) | Catalisador de combustao de oxido complexo de terra rara,processo para preparacao desto catalisador e uso deste catalisador | |
BR9600926A (pt) | Micelas mistas composições aquosas processo para a preparação de micelas mistas e uso | |
BR9610089A (pt) | Microemulsão não tóxica de óleo em água ou bicontínua processo para sua preparação e uso da mesma | |
ES2123800T3 (es) | Composicion para el cuidado de la piel que contiene vaselina emulsionada. | |
ES554777A0 (es) | Metodo para preparacion de una suspension de microcapsulas homogenea extemporanea | |
AR004357A1 (es) | Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos. | |
ES2106472T3 (es) | Procedimiento para la preparacion de esferulas. | |
BR9704554B1 (pt) | utilizaÇço de lipÍdios complexos como adiÇÕes de estabilizaÇço para composiÇÕes farmacÊuticas de misturas de enzimas de digestço, composiÇÕes farmacÊuticas soléveis em Água e kit para preparaÇço de soluÇÕes aquosas. | |
ES2137549T3 (es) | Derivados antifungicos de sordaridina. | |
AR016869A1 (es) | Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspensionfarmaceutica | |
BR9916399A (pt) | Método para preparar uma vacina auxiliada por emulsão água/óleo inativada, e, conjunto de partes que podem ser usadas para a preparação de uma vacina auxiliada por emulsão água/óleo inativada | |
ES2105605T3 (es) | Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas. | |
FI945427A0 (fi) | Dynemisiinianalogien enantiomeerit, niiden valmistus ja käyttö | |
DE3761271D1 (de) | Hydraulischer schwingungsunterdruecker und dessen anwendung an ventilen und dergleichen. | |
DE69300017D1 (de) | Wässrige pharmazeutische Zubereitung von Natriumcromoglykat. | |
EA199900750A1 (ru) | Водная фармацевтическая композиция, включающая активный ингредиент, в высшей степени нерастворимый в воде | |
BR0012006A (pt) | Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr | |
BR9509925A (pt) | Composição e uso da composição para prevenção ou tratamento de infecção por hiv-1 | |
BR9608878A (pt) | Esmalte de unhas aquoso. | |
DE60018802D1 (de) | Emulgiertes gel | |
ES2015551B3 (es) | Procedimiento para metalizacion de fuerte adherencia de polieterimida. | |
PT83253B (pt) | Processo para a preparacao de p-acilaminobenzamidas | |
ITRM930764A0 (it) | Procedimento per la preparazione di leucocoloranti allo zolfo idrosolubili. (caso150-5689) | |
IT1291895B1 (it) | Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |